NCT01153139

Brief Summary

Repetitive transcranial magnetic stimulation has been shown to be moderately effective in the treatment of major depression. Theta burst stimulation (TBS) is a new form of rTMS that may exert larger effects. This sham-controlled study examines the effectivity of daily bilateral TBS to the dorsolateral frontal cortex over 6 weeks in 2x16 patients with major depression add on to the local standard of a combined pharmacological/psychotherapeutical treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Apr 2010

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 23, 2010

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 29, 2010

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

July 16, 2013

Status Verified

July 1, 2013

Enrollment Period

2.7 years

First QC Date

April 23, 2010

Last Update Submit

July 13, 2013

Conditions

Keywords

Transcranial Magnetic StimulationDepressionTheta Burst Stimulation

Outcome Measures

Primary Outcomes (1)

  • Number of responders (response = decrease of the Montgomery-Åsberg Depression Rating Scale for at least 50%)

    after the end of treatment (week 6)

Secondary Outcomes (3)

  • Change of the Hamilton rating scale for depression (HAMD 17)

    baseline, after the end of treatment (week 6)

  • Change of the Beck Depression Inventory (BDI)

    baseline, after the end of treatment (week 6)

  • Change of the Montgomery-Asberg rating scale for depression (MADRS) score

    baseline, after the end of treatment (week 6)

Study Arms (2)

bilateral theta burst stimulation to the DLPFC

EXPERIMENTAL

intermittent TBS (iTBS) to the left DLPFC continuous TBS (cTBS) to the right DLPFC

Device: Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation, TBS)

Sham stimulation

PLACEBO COMPARATOR

Sham stimulation with a 45° tilted coil

Device: Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation, TBS)

Interventions

intermittent TBS (iTBS) to the left DLPFC (600 stimuli, 80% resting motor threshold) continuous TBS (cTBS) to the right DLPFC (600 stimuli, 80% resting motor threshold)

Sham stimulationbilateral theta burst stimulation to the DLPFC

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • major Depression
  • informed consent

You may not qualify if:

  • seizures in medical history
  • metallic implants
  • deep brain stimulation
  • cardiac pacemaker
  • brain trauma
  • psychotic symptoms
  • substance abuse
  • pregnancy
  • Benzodiazepines other than Lorazepam \>1mg/d

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Tübingen, Department of Psychiatry and Psychotherapy

Tübingen, Germany

Location

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med.

Study Record Dates

First Submitted

April 23, 2010

First Posted

June 29, 2010

Study Start

April 1, 2010

Primary Completion

December 1, 2012

Study Completion

July 1, 2013

Last Updated

July 16, 2013

Record last verified: 2013-07

Locations